Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mainly caused by asbestos exposure and refractory to current therapies. Specific diagnostic markers for early MPM diagnosis are needed. Changes in miRNA expression have been implicated in several diseases and cancers, including MPM. We exa...
Main Authors: | Tommaso Cavalleri, Laura Angelici, Chiara Favero, Laura Dioni, Carolina Mensi, Claudia Bareggi, Alessandro Palleschi, Arianna Rimessi, Dario Consonni, Lorenzo Bordini, Aldo Todaro, Valentina Bollati, Angela Cecilia Pesatori |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5417506?pdf=render |
Similar Items
-
An EBC/Plasma miRNA Signature Discriminates Lung Adenocarcinomas From Pleural Mesothelioma and Healthy Controls
by: Alice Faversani, et al.
Published: (2021-06-01) -
Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos
by: Claudio BIANCHI, et al.
Published: (2018-05-01) -
Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
by: Luca Ferrari, et al.
Published: (2020-04-01) -
Pleural Mesothelioma with No Asbestos Exposure: A Case Report
by: Salma Ait Batahar, et al.
Published: (2016-11-01) -
Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature
by: Cátia Santos, et al.
Published: (2023-01-01)